Hepatitis C infection in cadaver organ donors: strategies to reduce transmission of infection and prevent organ waste

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pediatric nephrology (Berlin, West)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00867679PMID 7492482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transmission of hepatitis C by kidney transplantation--the risks.

  1994cited by this paper
• Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study.

  1994influential reference
• Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group.

  1993cited by this paper
• Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

  1993cited by this paper
• Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantation.

  1993cited by this paper
• Donor hepatitis C antibody virus testing in renal transplantation.

  1993cited by this paper
• Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease Roth D, Fernandez JA, Babischkin S, De Mattos A, Buck BE, Quan S, Olson L, et al., Ann Intern Med 1992;117:1705–1709

  1993cited by this paper
• Transmission of hepatitis C virus by renal transplantation.

  1993cited by this paper
• Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection.

  1993cited by this paper
• Lack of protective immunity against reinfection with hepatitis C virus.

  1993cited by this paper
• Detection of Hepatitis C Virus Infection among Cadaver Organ Donors: Evidence for Low Transmission of Disease

  1992cited by this paper
• Transmission of HCV by organ transplantation.

  1992cited by this paper
• Medical evaluation of children adopted from abroad.

  1992cited by this paper
• Transmission of HCV by organ transplantation.

  1992cited by this paper
• Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.

  1992cited by this paper
• Lack of protective immunity against reinfection with hepatitis C virus

  1992cited by this paper
• Transmission of HCV by organ transplantation.

  1992cited by this paper
• Impact of specimen handling and storage on detection of hepatitis C virus RNA

  1992cited by this paper
• Antibodies to hepatitis C virus in kidney transplantation.

  1992cited by this paper
• The declining risk of post-transfusion hepatitis C virus infection.

  1992cited by this paper
• Sensitivity of serological assays to identify blood donors with hepatitis C viraemia.

  1992cited by this paper
• A study of renal transplants obtained from anti-HCV positive donors.

  1991cited by this paper
• Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C.

  1991cited by this paper
• Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

  1991cited by this paper
• Hepatitis C virus in cadaver organ donors: prevalence and risk of transmission to transplant recipients.

  1991cited by this paper
• Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease

  1991influential reference
• Transmission of hepatitis C virus by organ transplantation.

  1991cited by this paper
• A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

  1991cited by this paper
• Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses.

  1991cited by this paper
• Kidney transplants with positive anti-hepatitis C virus donors.

  1990cited by this paper
• Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users.

  1990cited by this paper
• Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

  1990cited by this paper
• Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.

  1990cited by this paper
• Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.

  1990cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

  1990cited by this paper
• Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.

  1989cited by this paper
• Avoiding false positives with PCR

  1989cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

  1989cited by this paper
• Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

  1989cited by this paper
• Liver disease in recipients of long-functioning renal allografts.

  1985cited by this paper
• Impact of hepatitis on renal transplantation.

  1981influential reference

• The use of organs from hepatitis C virus-viremic donors into uninfected recipients

  2020cites this paper
• Challenges and future developments in liver transplantation.

  2019cites this paper
• Cryopreserved bone allograft for the treatment of shoulder instability with glenoid defect.

  2018cites this paper
• Liver transplantation from HCV RNA-positive donors in the era of interferon-free HCV therapeutics: a re-examination of the situation.

  2017cites this paper
• Interferon-free antiviral therapy for chronic hepatitis C among patients in the liver transplant setting.

  2017cites this paper
• Current challenges and future directions for liver transplantation

  2017cites this paper
• Antiviral treatment of hepatitis C in renal transplant patients - safety issues

  2017cites this paper
• Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.

  2016cites this paper
• Characterization and risk of blood-borne virus transmission in organ transplantation: what are the priorities?

  2014cites this paper
• Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time

  2012cites this paper
• Histological evolution of hepatitis C virus infection after renal transplantation

  2012cites this paper
• Effects of Hepatitis C-Induced Liver Fibrosis on Survival in Kidney Transplant Candidates

  2007cites this paper
• Should antihepatitis B virus core positive or antihepatitis C virus core positive subjects be accepted as organ donors for liver transplantation?

  2007cites this paper
• Outcome of Hepatitis C Virus‐Infected Kidney Transplant Candidates Who Remain on the Waiting List

  2005cites this paper
• Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors

  2005cites this paper
• Kidney transplantation from hepatitis C virus-positive donors into hepatitis C virus-positive recipients: a safe way to expand the donor pool?

  2005cites this paper
• Hepatitis C in transplantation

  2005cites this paper
• Hepatitis C and renal disease: an update.

  2003cites this paper
• Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus)

  2002cites this paper
• Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus)

  2002cites this paper
• Organ-transmitted HCV infection in kidney transplant recipients from an anti-HCV negative donor.

  1999cites this paper
• Hepatitis C virus infection in dialysis and renal transplantation.

  1997cites this paper
• Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement.

  1997cites this paper
• Serologic responses to hepatitis C virus in solid organ transplant recipients.

  1997cites this paper
• A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.

  1995cites this paper